Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-06
DOI
10.3389/fendo.2020.00028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acromegaly
- (2019) Annamaria Colao et al. Nature Reviews Disease Primers
- Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain
- (2019) Carmen Peral et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Hypertension and Acromegaly
- (2019) Soraya Puglisi et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly
- (2018) Baldomero González et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
- (2018) Alessia Cozzolino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
- (2018) Francesco Ferraù et al. Frontiers in Endocrinology
- Postoperative use of somatostatin analogs and mortality in patients with acromegaly
- (2018) Mark R Postma et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
- (2018) Federico Gatto et al. Pituitary
- Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
- (2017) Ammar Muhammad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center
- (2017) John D. Carmichael et al. BMC Endocrine Disorders
- How to improve effectiveness of pegvisomant treatment in acromegalic patients
- (2017) M. Ragonese et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study
- (2016) Philippe J. Caron et al. CLINICAL ENDOCRINOLOGY
- Wpływ cukrzycy na przeżycie pacjentów z akromegalią
- (2016) Chiou Wen-Ko et al. Endokrynologia Polska
- Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly
- (2016) Chiara Sardella et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study
- (2016) Lakshminarayanan Varadhan et al. Pituitary
- Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
- (2016) Julie M. Silverstein Pituitary
- Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study
- (2016) Marcello D. Bronstein et al. BMC Endocrine Disorders
- Mortality in acromegaly: a 20-year follow-up study
- (2015) Elina Ritvonen et al. ENDOCRINE-RELATED CANCER
- Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
- (2015) Emmanuelle Kuhn et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pharmacokinetics and Safety of Subcutaneous Pasireotide and Intramuscular Pasireotide Long-acting Release in Chinese Male Healthy Volunteers: A Phase I, Single-center, Open-label, Randomized Study
- (2014) Xia Chen et al. CLINICAL THERAPEUTICS
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of Surgical Treatment of Acromegaly: Effects on Ghrelin, Weight, Adiposity, and Markers of CV Risk
- (2014) Carlos Reyes-Vidal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Successful Mortality Reduction and Control of Comorbidities in Patients With Acromegaly Followed at a Highly Specialized Multidisciplinary Clinic
- (2014) Moises Mercado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
- (2014) E. Ghigo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study
- (2014) Michael Sheppard et al. Pituitary
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
- (2013) Astrid Breitschaft et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A Comprehensive Study of Clinical, Biochemical, Radiological, Vascular, Cardiac, and Sleep Parameters in an Unselected Cohort of Patients With Acromegaly Undergoing Presurgical Somatostatin Receptor Ligand Therapy
- (2013) Anand K. Annamalai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Predictors of morbidity and mortality in acromegaly: an Italian survey
- (2012) M Arosio et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cardiovascular involvement in patients affected by acromegaly: An appraisal
- (2012) Susanna Mosca et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Metabolic Profile in Active Acromegaly is Gender-Specific
- (2012) A. Ciresi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly
- (2011) C. N. Jayasena et al. CLINICAL ENDOCRINOLOGY
- Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
- (2011) Sandrine Fieffe et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study
- (2011) Annamaria Colao et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Body Fluid Expansion in Acromegaly Is Related to Enhanced Epithelial Sodium Channel (ENaC) Activity
- (2011) Peter Kamenicky et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Changes in Arterial Stiffness But Not Carotid Intimal Thickness in Acromegaly
- (2011) A. N. Paisley et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study
- (2011) Carla Giordano et al. Pituitary
- Acromegaly per se does not increase the risk for coronary artery disease
- (2010) Hiroyoshi Akutsu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control
- (2010) Christian Berg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study
- (2009) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment
- (2008) Annamaria Colao et al. CLINICAL ENDOCRINOLOGY
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation